1 Min Read
May 11 (Reuters) - Novus Therapeutics Inc:
* NOVUS THERAPEUTICS SAYS HAD $22.5 MILLION IN CASH AND CASH EQUIVALENTS AS OF MARCH 31 - SEC FILING Source text: (bit.ly/2rza3AD) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.